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Abstract
 .The cationic lipohexapeptide Pam Cys–Ser– Lys is a synthetic model for the triacylated N-terminal part of bacterial3 4
lipoproteins, and it is used as an adjuvant and macrophage activator. The amphiphilic lipopeptide was injected below a
phosphatidylserine monolayer at the air–water interface. It interacted with the interface, as seen by a decrease in the surface
 .potential DV , and it was inserted in the monolayer, until surface charge neutralization was reached, as seen by the parallel
increases of DV and of the surface pressure. No insertion occurred above 29 mNrm. The interaction kinetics was sensitive
to ionic strength and to the nature of acidic phospholipids and of their acyl chains, but the final equilibrium was independent
 .of these factors. Addition of the lipopeptide to large unilamellar vesicles LUVs induced their aggregation, and an
exchange of lipids between fluorophor-labelled and non-labelled LUVs. However, no fusion was observed, just as reported
for polylysine. The lipopeptide strongly inhibited calcium-induced fusion of PS LUVs, in contrast to the published effect of
polylysine. This was probably due to inhibition of calcium fixation on liposomes, since it was observed that the lipopeptide
efficiently displaced 45Ca2q from a PS monolayer. In addition, a phospholipid segregation was observed in SUVs for a few
ten micromolar of the lipopeptide. q 1998 Elsevier Science B.V.
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1. Introduction
Lipoproteins present in the cytoplasmic membrane
or in the outer envelopes of Gram positive and
negative bacteria share the same N-terminal S-
glyceryl-cysteine residue bearing three fatty acyl
chains: one is amide-linked and the two others are
ester-linked to the 2,3-dihydroxypropyl residue at-
tached to the sulphur atom of cysteine. The first
bacterial lipoprotein described was Braun’s lipopro-
w xtein 1 , present in the outer membrane of E. coli. It
has been shown that this lipoprotein stimulates B-
w xlymphocytes 2 . Lipoproteins from other bacteria
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were found to be major immunogens, for instance
that from Treponema pallidum or from Borrelia
w xburgdorferi 3,4 .
It appeared that the acylated N-terminal moieties
were responsible for the activity of these lipoproteins
w xon B-cells of the immune system 5–7 . Subse-
quently, many lipopeptide analogues have been syn-
thesized and tested, in order to obtain immunostimu-
lating molecules easier to prepare than the bacterial
w xlipoproteins 8,9 . Very few biophysical studies have
been performed with such molecules: the molecular
area of anionic lipopeptides at the air–water interface
w xhas been determined 10 , and it has been shown that
neutral and cationic lipopeptides have an affinity for
w xliposomes and cell membranes 11 .
One of the most promising synthetic lipopeptides,
due to its biological activity and to its high water
solubility, bears three palmitic acid residues on its
 .N-terminal hexapeptidic moiety Cys–Ser– Lys . It4
 .  .can be abbreviated Pam Cys–Ser– Lys Fig. 1 and3 4
it will be designated below as the ‘‘lipopeptide’’.
This cationic lipopeptide has been shown to activate
w xmacrophages and B-lymphocytes 12 , to stimulate
w xtyrosine phosphorylation in human myeloid cells 13 ,
to activate superoxide formation in human neu-
w x w xtrophils 14 and HL-60 leukemic cells 15 . The
lipopeptide is clearly amphiphilic with three palmitic
acid residues and three net positive charges. Nothing
is known of its interaction with membrane lipids,
especially with anionic lipids, an interaction that can
be at the origin of some of the pleiotropic effects
observed with this lipopeptide.
In the present work we studied the interaction of
the lipopeptide with phospholipids in two model sys-
tems, i.e. monolayers at the air–water interface and
 .large unilamellar vesicles LUVs . Interactions with
Fig. 1. Structure of the cationic lipohexapeptide Pam Cys–Ser–3
 .Lys .4
phosphatidylserine, the most abundant anionic phos-
pholipid in animal cells, were examined. Our results
are discussed with respect to literature data on oligo-
and poly-lysine peptides interacting with anionic
phospholipids. This comparison underscores the ma-
jor influence of acyl chains of the lipopeptide on its
properties.
2. Materials and methods
2.1. Chemicals
Bovine brain phosphatidylserine saturatedrun-
.saturated acyl chainss0.95 , dipalmitoyl-sn-glycero-
3-phosphoserine, egg phosphatidylcholine and egg-
derived phosphatidylgycerol saturatedrunsaturated
.acyl chainss0.80 , 1-palmitoyl,2-oleyl-3-phospho-
 .sn-glycerophosphoglycerol POPG , 1,2-dioleyl-sn-
glycero-3-phosphoethanolamine-N- 7-nitro-2-1,3-ben-
.zoxadiazol-4-yl called PE – N B D , phos -
phatidylethanolamine-N- lissamine rhodamine b-
. sulfonyl called PE–rhodamine and 1-acyl,2- 6-
.NBD-hexanoyl -sn-glycero-3-phosphocholine called
NBD–PC, were obtained from Avanti Polar Lipids
 .  .Alabaster, USA . 4 5 -carboxyfluorescein was ob-
 .tained from Fluka Buchs, Switzerland . Terbium
 .III chloride hexahydrate and 2,6-pyridinedicarbo-
 .  .xylic acid DPA , 2- p-toluidino naphthalene-6-
 .  .sulfonic acid TNS , fluorescamine, trilysine Lys3
 .  .and 3- N-morpholine propanesulfonic acid MOPS
were obtained from Sigma-Aldrich St. Quentin,
.France . 8-Aminonaphthalene-1,3,6-trisulfonic acid
 .  .ANTS , p-xylene bispyridinium bromide DPX and
 .1,6-diphenyl-1,3,5-hexatriene DPH were obtained
 .  .from Molecular Probes Eugene, USA . S- 2,3 bis-
 .  . .palmitoyloxy - 2 RS -propyl -N-palmitoyl-Cys–
 .Ser–Lys –OH Pam Cys–Ser–Lys was obtained4 3 4
 . 45from Boehringer Mannheim-France Meylan . Ca
 .45 GBqrmmol was obtained from Amersham-
 .  .France Les Ullis . Stock solutions 1 mM of the
lipopeptide were prepared in ultrapure water. Organic
solvents were glass-distilled and stored in glass con-
tainers. Water phases for monolayers were prepared
 .with ultrapure water MilliQ, Millipore . Carboxyflu-
orescein was purified by ethanol precipitation and
w xfiltration through a Sephadex LH20 column 16 .
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2.2. Synthesis of the NBD deri˝ati˝e of the lipopep-
( ) ( ) (tide, Pam Cys–Ser– Lys –Lys NBD –OH called3 3)lipopeptide–NBD
Resin and reagents were purchased from Cal-
 .biochem-Novabiochem Bad Soden, Germany . Sol-
vents were obtained from Fluka and N-palmitoyl-S-
 .  .  . 2,3-bis palmitoyloxy - 2 RS propyl- R -cysteine i.e.
.Pam Cys–OH was synthesized as described previ-3
w xously 17 . The lipopeptide was built up using the
 .fluorenylmethoxycarbonyl Fmoc protocol for solid
phase synthesis on an Applied Biosystems model
433A automated synthesizer. A Wang-PHB-resin
loaded with Dde-protected Fmoc–lysine residue was
used as solid support. Resin substitution was
0.6 mmlrg and 0.1 mmol of aminoacid was used for
each coupling. The following side chain protecting
 .  groups were employed: Lys t-butoxy , Lys 1- 4,4-
. .dimethyl-2,6-dioxo-cyclohexylidene ethyl and Ser
 . t-butyl . Aminoacids were coupled using 2- 1H-ben-
.zotriazole-1-yl -1,1,3,3-tetramethyluronium tetrafluo-
 .roborate and hydroxybenzotriazole TBTUrHOBt .
Pam Cys–OH was coupled in double excess to the3
resin-bound N-5mer-peptide with diisopropylcarbodi-
im id e r H O B t in d im e th y lfo rm a m id e r
 . w xdichloromethane 1:2 for 12 h 18 . The Dde-
protecting group was selectively removed by hydra-
 .zine 5% in dimethylformamide . Then 7-chloro-4-
nitrobenz-2-oxa-1,3-diazole in dimethylformamide
was coupled in 10 fold excess to the C-terminal
lysine deprotected in the lysine side chain. The pep-
tide and all protecting groups were cleaved from the
 .resin with TFA containing phenol 5% , ethanedithiol
 .  .5% and water 7% . The synthesis was monitored
by electrospray ionisation mass spectrometry on a
triple quadrupole instrument API III TAGA X PE
.Sciex, Thornhill, Canada .
2.3. Monolayers at the air–water interface
Compression isotherms were obtained as previ-
ously described, using a Wilhelmy platinum plate to
determine surface pressure with an apparatus con-
w xstructed in the laboratory 19 . Briefly, 10 ml of the
 .lipid solution CHCl rCH OH, 7r3 v:v was care-3 3
fully deposited on the water phase, and a 15 min lag
time was observed for solvent evaporation. A 5 mM
MOPS, pH 7.4 buffered water phase was used. The
compression isotherms presented are the average of
at least three runs. They were reproducible within
0.04 nm2rmol.
Insertion of the lipopeptide into phospholipid
monolayers and detection of 45Ca2q at the interface
were performed in a teflon trough with a fixed area
 2. 16 cm and a 10 ml subphase 5 mM MOPS, pH 7.4
for lipopeptide insertion; 1 mM NaCl, pH 6.8 for
2q .Ca detection . Films at the chosen surface pres-
sures were obtained by successive molecule deposits.
Solutions were introduced underneath the monolayer
with a syringe through a side hole. The lipopeptide
concentration of 7 mM in the water phase was chosen
in order to reach the surface pressure plateau within
1 h with all the anionic phospholipids used to prepare
monolayers. There was slow magnetic stirring of the
water phase throughout the experiment.
2.4. Liposomes
 .Large unilamellar vesicles LUV were prepared
w xby the reverse-phase method 20 , except when other-
wise stated for specific experiments. Briefly, lipids
were dissolved in 1 volume of peroxide-free diethyl
ether and 0.3 volume of buffered saline solution,
calculated to obtain a 10 mM final lipid concentra-
tion, were injected rapidly. After brief sonication in
.a bath , ether was removed using a rotatory evapora-
tor at 350 mbar and 458C, until gel formation. The gel
was collapsed by a brief vortex mixing, and evapora-
tion was continued at 150 mbar for 5 min. Then 0.7
volume of buffer saline was added and evaporation
resumed for 20 min to eliminate residual diethyl ether.
To achieve uniform size distribution, vesicles were
extruded through a polycarbonate membrane 0.6 and
.0.1 mm – Avanti Polar Lipids Mini-extruder system .
Non-entrapped probes were eliminated on a Sephadex
G50 column. The final phospholipid content of lipo-
somes was calculated after phosphorus determination
w xaccording to 21 .
2.5. Binding to liposomes
The binding of the lipopeptide and of trilysine to
POPG LUV was characterized by their respective
apparent m olar partition constant K s
 .  . . w xbound r free accessible lipid 22 . Bound and free
peptide concentrations were determined by fluo-
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rescamine, using sucrose-loaded LUV in order to
separate peptides bound to LUV from free peptides
w xby centrifugation 23 .
2.6. Release of encapsulated material
LUVs loaded with 100 mM carboxyfluorescein in
10 mM MOPS, 5 mM Na SO , 0.1 mM EDTA, pH2 4
7.4, were diluted to 50 mM phospholipids in the same
buffer containing 105 mM Na SO . Carboxyfluores-2 4
cein leakage was followed by fluorescence spec-
 .troscopy l 470 nm, l 519 nm . 100% leakexc. emis.
was estimated by adding Triton X100 0.1% final
.concentration ; leakage was expressed as the ratio
 .  .F yF r F yF , with x corresponding to thex 0 100 0
fluorescence intensity of the considered assay, 0
stands for the initial intensity at time 0 and 100 for
the intensity after addition of Triton X100.
2.7. Lipid mixing assay
Lipid mixing between liposomes was detected
through the inhibition of energy transfer between two
fluorophores inserted together in liposomes. Experi-
w xments were carried out according to 24 , briefly:
LUVs prepared with phosphatidylserine 10 mM final
.concentration containing 1% PE–NBD plus 1%
PE–rhodamine were mixed in a cuvette 10 mM PS
. final concentration with non-labelled LUVs 40 mM
.PS final concentration in 100 mM NaCl, 10 mM
MOPS, 0.1 mM EDTA, pH 7.4. It was chosen to
detect lipid mixing by measuring the NBD fluores-
cence increase. NBD fluorescence was monitored
with l 460 nm and l 534 nm. 100% fluores-exc. emis.
cence increase was determined by addition of Triton
 .X100 to the samples 1% final concentration , with a
correction factor of 1.5 due to fluorescence quench-
ing by the detergent. Fluorescence was measured
either with a JY3 Jobin et Yvon or an Aminco SPC
500 C.
2.8. Fusion assay
Two techniques were used to monitor intermixing
of the aqueous contents of the LUVs: the terbiumrdi-
w xpicolinic acid assay 20 , and the ANTSrDPX assay
w x25 . In both assays, fusion of liposomes resulted in
the formation of a complex, fluorescent or quenched,
respectively. Each assay was performed with 50 mM
phosphatidylserine, in 100 mM NaCl, 10 mM MOPS,
1 mM EDTA, pH 7.4.
2.9. TNS assay
The method used was that designed to probe the
w xelectrostatic surface potential of liposomes 26 .
 .Briefly, TNS 0.11 mM final concentration was added
to LUVs in 100 mM NaCl, 10 mM MOPS, pH 7.4,
and the lipopeptide was progressively added. Fluores-
cence was recorded after each addition l 321 nm,exc.
.l 445 nm .emis.
2.10. Phospholipid segregation
Phospholipid segregation was detected according
w xto Hoekstra 27 , briefly: small unilamellar vesicles
 .SUV were prepared in 0.1 NaCl, 0.01 mM MOPS,
 .pH 7.4, by sonication 50W of mixture of brain–PS
 .and NBD–PC 9r1, molar ratio ; segregation of
NBD–PC induced either by calcium or by the
lipopeptide was followed by measuring fluorescence
with narrow band-pass slits and crossed polarizers to
eliminate light diffusion.
3. Results
3.1. Lipopeptide solutions
The lipopeptide is clearly soluble in water up to a
concentration of about 1 mM. Because of its am-
 .phiphilic structure Fig. 1 , it was examined whether
the lipopeptide was able to form micelles. Increasing
amounts of the lipopeptide were added into a cuvette
 .containing diphenylhexatriene DPH . Fluorescence
w xintensity and polarization measurements of DPH 28
showed smooth variations between 2 and 200 mM
lipopeptide concentration, but no critical concentra-
tion, corresponding to the formation of a new phase,
could be observed. Thus it is quite likely that the
lipopeptide does not form micelles in the tested con-
centration range. In addition, it is worth noting that
no monolayer formation was detected at the interface
between air and lipopeptide solutions, since no varia-
tion of the surface pressure was detected 1 h after
( )J. Gonzalez-Christen et al.rBiochimica et Biophysica Acta 1368 1998 97–107 101
addition of the lipopeptide into the water phase 7mM
.final concentration .
3.2. Lipopeptide interaction with preformed phospho-
lipid monolayers
Lipopeptide solutions were introduced into the wa-
ter phase underneath preformed phospholipid mono-
layers with a fixed area. Injection of the lipopeptide
into the water phase resulted in an increase of the
surface pressure with each of the three types of
 .anionic monolayers used PS, DPPS, PG , indicating
  ..an insertion of the lipopeptide in the film Fig. 2 A .
No insertion was observed in the neutral phos-
phatidylcholine monolayer. The final surface pressure
was the same for the three anionic lipids, but kinetics
were different, indicating an influence of the nature
of the polar head and of the state of acyl chain
Fig. 2. Lipopeptide interaction with a preformed phospholipid
 . monolayer. A Kinetics of interaction. The lipopeptide final
y6 . concentration 7=10 M was injected in the water phase 5 mM
.MOPS, pH 7.4 below a monolayer prepared at a 20 mNrm
initial surface pressure. Open circles: brain phosphatidylserine
 .  .PS , full squares: dipalmitoylglycerophosphorylserine DPPS ,
 .  .full triangles: egg-derived phosphatidylglycerol PG . B Surface
 .pressure increase Dp due to lipopeptidermonolayer interac-
 .tion. Monolayers were prepared at various surface pressures p i
and the lipopeptide was injected in the water subphase. full
circles: Dp versus p at the equilibrium between free and boundi
lipopeptide; open squares: Dp calculated from compression
 .isotherms Fig. 3 , i.e. the Dp between a monolayer of PS alone
and of a 1r3 lipopeptiderPS mixture.
Fig. 3. Compression isotherms of PS and of a lipopeptiderPS
 .mixture. PS alone isotherm A or a mixture of lipopeptiderPS
 .1r3 molar ratio; isotherm B was spread on 5 mM MOPS, pH
 .7.4. The films were compressed and the surface pressure mNrm
 2.versus the molecular area nm calculated for one PS molecule
was recorded. Arrows present an example of the determination of
 .Dp vertical arrow that could be expected from insertion of the
lipopeptide within a PS monolayer at the initial lateral pressure
 .p s15 mNrm horizontal arrow .i
organization on kinetics but not on the final equilib-
rium state. Thus electrostatic interactions played a
major role in the lipopeptide insertion in the mono-
layer. This type of interaction is very sensitive to
ionic strength, as noted with polymyxin, an am-
w xphiphilic cationic peptide 29 , or with oligo- and
w xpolylysine 30–33 .
Phosphatidylserine monolayers were prepared at
15 mNrm on the 5 mM MOPS buffer with or without
300 mM NaCl. The same maximum surface pressure
increase was obtained on both subphases, indicating
that the final equilibrium was not dependent on ionic
 .strength data not shown , or in other words that
electrostatic forces are not the only one involved in
the lipopeptiderphospholipid interaction.
Insertion experiments were repeated with films at
 .various initial surface pressures P and the surfacei
 .pressure increase D P was determined after the
equilibrium was reached: no insertion of the lipopep-
tide in the film was detected above P s29 mNrmi
  ..Fig. 2 B . The lipopeptide bears three net positive
charges, therefore, it was checked whether the final
surface pressure obtained in the above experiments
corresponded to what can be estimated from com-
pression isotherms performed either with PS alone or
with a lipopeptiderPS mixture in the 1r3 molar ratio
 .Fig. 3 . The D P values calculated as indicated in
the legend of Fig. 3 from these two isotherms are
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 .presented in Fig. 2 B . Comparison with D P values
obtained at equilibrium between a PS monolayer and
  ..the lipopeptide injected in the subphase Fig. 2 B
shows a good agreement between the two set of data,
 .up to a final pressure P qD P of about 20 mNrmi
 .i.e. up to about P s10 mNrm , while a significanti
deviation was observed for higher values.
In order to obtain informations on electrostatic
interactions in the above experiments, the surface
potential DV of a PS monolayer interacting with the
 .lipopeptide was determined Fig. 4 . DV depends on
the electric charges present at the waterrlipid inter-
face and on the permanent dipole moments of the
film-forming molecules. Thus, DV is expected to be
influenced by the orientation of the molecules within
the monolayer, and by the molecules adsorbed at the
interface. Monolayers prepared by spreading mixtures
with known molar percentages of lipopeptide to
phosphatidylserine presented a surface potential much
 .Fig. 4. Surface potential DV of lipopeptiderphosphatidylserine
 .  .monolayers. A Surface potential of monolayers 26 mNrm
formed by spreading lipopeptiderPS mixtures molar percentages
.as indicated in abcissa . Abcissa: molar percentages of lipopep-
tide to total molecules. The vertical dotted line indicates the
molar percentages corresponding to charge neutralization of the
monolayer by the lipopeptide. DV determinations were repro-
 .ducible within 5 mV. B Surface potential and surface pressure
variations with for a monolayer of PS, after injection of the
lipopeptide into the subphase. Time 0 corresponds to the injection
of the lipopeptide under the monolayer. Full squares: surface
pressure; open triangles: surface potential.
higher above the ratio of 1 lipopeptider3 phos-
 .   ..phatidylserines charge neutralization Fig. 4 A .
After injection of the lipopeptide in the water phase
below a preformed monolayer of phosphatidylserine
alone, DV dropped quickly, then steadily increased
 .up to a much higher value 350 mV than that mea-
 .   ..sured at time 0 250 mV Fig. 4 B . The small
initial decrease of DV could be due to the arrival of
the lipopeptide as a counter-ion at the monolayer
interface, without insertion in the monolayer, since
the surface pressure did not change. Then the
lipopeptide molecules were progressively inserted into
the monolayer, as indicated by the increase in surface
pressure, with a correlative charge neutralization of
phosphatidylserine, leading to a large and progressive
increase of DV. It is worth noting that the DV value
 .obtained at the plateau 350 mV after injection of the
  ..lipopeptide under the monolayer Fig. 4 B , was
 .similar to that obtained for the lipopeptiderPS 1r3
mixture which corresponds to charge neutralization in
  ..the monolayer Fig. 4 A . This strongly suggests that
lipopeptide molecules were inserted from the water
phase into the monolayer up to charge neutralization.
3.3. Effects on liposomes
Association of the lipopeptide and of trilysine
presenting three positive net charges as the lipopep-
.tide with phosphatidylglycerol LUV was character-
ized by titrating the lipopeptide by fluorescamine.
w xThe apparent molar partition constant 22 of the
lipopeptide and of trilysine were 2=105 and 2.5=
102 My1, respectively.
Interaction of bacterial lipids with a phospholipid
bilayer can induce an alteration of membrane passive
permeability, as it was shown for mycobacterial gly-
w xcopeptidolipids 34 . The three positive net charges of
the lipopeptide might also facilitate fusion of nega-
tively charged membranes, as it is well documented
w xfor polylysine molecules 35,36 . The occurrence of
these two effects was investigated with the lipopep-
tide interacting with large unilamellar vesicles
 .LUVs .
LUVs entrapping carboxyfluorescein were ob-
tained using the technique of reverse-phase evapora-
tion followed by extrusion through polycarbonate
 .membranes. One phospholipid PC, PS or binary
( )J. Gonzalez-Christen et al.rBiochimica et Biophysica Acta 1368 1998 97–107 103
Fig. 5. Lipopeptide-induced leaks in large unilamellar vesicles
 .LUVs . Insert: example of an assay; time 0 corresponds to the
moment of the lipopeptide addition to carboxyfluorescein-loaded
LUVs. Open squares: PS LUVs; full circles: PCrPS LUVs 3r1,
.molar ratio ; full squares: PC LUVs. The vertical dotted line
 .indicates the molar ratio 1r6 corresponding to charge neutral-
ization of the PS LUV outer layer. 100% fluorescence increase
corresponds to the fluorescence intensity after addition of Triton
 .X100 1% final concentration .
 .mixtures PCrPS; 3r1, molar ratio were used. Ad-
dition of the lipopeptide to negatively charged PS-
containing liposomes induced a fluorescence increase
 .Fig. 5 , not observed with neutral PC liposomes. The
leak reached a maximum for a lipopeptiderPS ratio
around 1r6, a ratio corresponding to charge neutral-
ization of half the PS molecules, i.e. the PS molecules
which are present in the outer layer of the liposomes.
However, this leak was limited in intensity less than
. 25% of a detergent-induced leak and transient less
.than 1 min – insert in Fig. 5 . Permeabilisation of
liposomes as observed with the anionic carboxyfluo-
rescein was not due to an interaction with the cationic
lipopeptide, since it was also observed with terbium
 .ions data not shown .
In addition to the release of part of the entrapped
materials, the lipopeptide induced aggregation of li-
posomes, as seen by light scattering measurements
 .data not shown . These data were reminiscent of
what has been observed in liposome fusion experi-
w xments performed in the presence of polylysine 36 .
The ability of the lipopeptide to induce fusion was
then investigated.
Fusion was first detected by following the decrease
in energy transfer between two fluorescent probes in
liposomes doubly labelled phosphatidylethanol-
amine–NBD plus phosphatidylethanolamine–rhod-
.amine . This labelled liposomes were brought in con-
w xtact with non-labelled liposomes 20 and the NBD
fluorescence increase was measured.
Addition of the lipopeptide to liposomes induced a
 .dose-dependent NBD fluorescence increase Fig. 6 ,
indicating a mixing of membranes, up to a maximum
beginning at a ratio of about 1 lipopeptide to 7 PS.
To correlate the extent of membrane mixing with the
net external surface charge of liposomes, the known
possibility to probe the electrostatic surface potential
w xof liposomes with TNS was used 37 : a large and
fast fluorescence increase occurred upon addition of
lipopeptide to liposomes in the presence of TNS,
followed by a progressive decrease in fluorescence
 .insert in Fig. 7 . As it was observed that the fluores-
cence of TNS was greatly increased in the presence
 .of free lipopeptide molecules data not shown , the
 .initial increase observed insert in Fig. 7 is likely to
correspond to an early TNSrlipopeptide interaction,
followed by the progressive break down of this asso-
ciation due to the insertion of the lipopeptide into
liposome outer layer, leading to a decrease in TNS
fluorescence down to a plateau.
Successive additions of lipopeptide to liposomes
progressively reduced the surface charge of lipo-
somes; addition of the lipopeptide in excess of charge
Fig. 6. Mixing of membranes of labelled and non-labelled LUVs.
Mixing of membranes was determined by measuring the fluores-
cence of NBD–PE after addition of the lipopeptide. 100% corre-
sponds to the fluorescence obtained after addition of Triton X100
 .1% final concentration . The vertical dotted line indicates the
 .molar ratio 1r6 corresponding to charge neutralization of the
LUV outer layer.
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Fig. 7. Charge neutralization of phosphatidylserine LUVs by the
lipopeptide, detected by TNS fluorescence. The vertical dotted
 .line indicates the molar ratio 1r6 corresponding to charge
neutralization of LUV outer layer. Insert: example of an assay;
time 0 corresponds to the moment of addition of the lipopeptide.
neutralization resulted in an increase in fluorescence
due to interactions of TNS molecules both with the
neutral surface of liposomes and with free lipopep-
tide. Fluorescence at the plateau increased for
 .lipopeptiderPS ratios above 1r7 Fig. 7 , i.e. a ratio
corresponding in Fig. 6 to the lowest ratio inducing
the maximum phospholipid exchange between lipo-
somes. As the lipopeptide bears three net positive
charges, it appears that the lipopeptide induced maxi-
mum mixing of liposomal membranes provided the
liposome outer surface was close to electrical neutral-
ity. However, the lipopeptide did not induce any
mixing of the liposome contents, as shown by using
either the terbiumrDPA or the ANTSrDPX systems
 .of fusion detection data not shown . Thus, the
lipopeptide induced an exchange of lipids between
liposomes, but not liposome fusion. This was remi-
niscent of what has been proposed for the effect of
w xpolylysine 38 .
Because polylysine has been shown to facilitate
calcium-induced fusion by promoting liposome ag-
w xgregation 35 , a similar effect was sought for the
lipopeptide. It appeared that the lipopeptide strongly
inhibited calcium-induced fusion even for low
lipopeptiderPS ratios, as seen with the ANTSrDPX
 .system Fig. 8 and with the terbiumrDPA system
 .data not shown . Fusion was completely inhibited
when the outer surface net charge of the liposomes
was neutralized by the lipopeptide. A peptide tri-
.lysine with the same net charge as the lipopeptide
had no effect on fusion, in the concentration range
used for the lipopeptide.
As fusion was induced by calcium, two experi-
ments were performed with PS monolayers to check
whether a competition for binding at the interface
could occur between calcium and the lipopeptide.
Firstly, the surface pressure increase induced by the
lipopeptide in preformed monolayers was followed in
the presence of Ca2q: up to 50 mM Ca2q, no signifi-
cant decrease of the lipopeptide interaction was de-
tected, and a 50% reduction in the surface pressure
increase was noted in the presence of 500 mM Ca2q
  ..Fig. 9 A . Secondly, a PS monolayer was formed
on a water phase containing 45Ca2q. An increase in
surface radioactivity due to an increase in calcium
concentration at the interface was observed. Then,
addition of the lipopeptide into the water phase re-
sulted in a progressive and large decrease in radioac-
  ..tivity Fig. 9 B . This showed that the lipopeptide
displaced calcium from the phosphatidylserine mono-
 .layer. As seen in Fig. 9 B , trilysine at the same
concentration had a much weaker effect.
The lipopeptide bearing three positive net charges,
it can interact with three PS molecules, thus it could
induce a local segregation of PS molecules. An indi-
rect experimental evidence was obtained with PS–
Fig. 8. Effect of the lipopeptide on calcium-induced fusion of
LUVs. The fluorescence of ANTS was used to follow calcium-in-
 2q .duced fusion 3 mM Ca final concentration of LUVs loaded
either with ANTS or with its quencher DPX. 100% corresponds
to the fluorescence measured after calcium-induced fusion, in the
absence of trilysine or of the lipopeptide. Full squares: effect of
the lipopeptide; open squares: effect of trilysine. The vertical
 .dotted line indicates the molar ratio 1r6 corresponding to
charge neutralization of the LUV outer layer.
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Fig. 9. Calcium and lipopeptide adsorption on a PS monolayer
 .A Lipopeptide adsorption in the presence of calcium. The
 .lipopeptide 7 mM final concentration was injected below PS
monolayers formed on water phases containing various calcium
concentrations. Open squares: initial surface pressure, full circles:
 .final surface pressure after addition of the lipopeptide. B Kinet-
ics calcium displacement from a phosphatidylserine monolayer,
after addition of the lipopeptide. Initial surface pressure,
20 mNrm.; 15mM 45Ca2q in the subphase. The added lipopep-
tide and trilysine were at a final concentration of 0.6 mM. Time 0
corresponds to the moments of additions. Full squares: lipopep-
tide; open squares: trilysine.
SUV containing 10% NBD–PC. This system has
been used to detect calcium-induced segregation of
PS that created NBD–PC rich domains, resulting in a
w xself-quenching of the fluorescent probe 27 . Addition
of the lipopeptide in concentration above 20 mM
induced up to 30% quenching of NBD fluorescence,
while calcium concentrations in the millimolar range
were necessary to obtain the same result data not
.shown .
4. Discussion
 .The lipohexapeptide Pam Cys–Ser– Lys shows3 4
strong interactions with anionic phospholipids PG,
.PS , but not with the neutral PC. This behaviour was
expected because of its three positive net charges.
However, electrostatic interactions are not the only
ones contributing to the binding of the lipopeptide to
q  .lipids, since high Na concentrations 300 mM do
not inhibit these interactions, neither with monolayers
nor with liposomes. Interestingly, surface pressure at
  ..the plateau Fig. 2 A is identical for PG, PS and
DPPS, indicating that the final equilibrium is influ-
enced neither by the nature of the anionic polar head,
nor by the presence of saturated or unsaturated acyl
chains. However, the interaction kinetics is dependent
of these factors. The slowest insertion rate was ob-
served with DPPS, which formed the more condensed
films due to its saturated acyl chains. This suggests
that insertion of the lipopeptide in the acyl chain
region of the monolayer could be the kinetically
limiting step with DPPS.
It is obvious that the three palmitoyl chains of the
lipopeptide can exhibit hydrophobic interactions with
lipids. This is in agreement with the above determina-
tions of apparent association constants with PS–LUV,
since the lipopeptide constant is 103 times that of
trilysine. In addition, the tetramethylene groups of
lysine residues may also participate to such interac-
tions, as it has been shown for the lysine methyl ester
w xinteracting with PG monolayers 39 . Liposomes pre-
pared with the lipopeptide covalently linked to a
NBD fluorescent group on the C-terminal lysine
 .lipopeptide–NBD brought some informations on
the location in the interface of the tetralysine moiety,
since NBD fluorescence is very sensitive to the polar-
w xity of its environment 40,41 . When the lipopeptide–
NBD was inserted in liposomes made of PC alone, its
emission spectrum presented a small but significant
red-shift and a higher intensity as compared to the
 .labelled lipopeptide in PS liposomes data not shown .
This indicates that in PC liposomes, the fluorophore
is in a more polar environment than in PS liposomes.
It is known that lipid-linked NBD is located in the
w xglycerol region of the phospholipid bilayer 41 , thus
it can be postulated that the NBD moiety of the
lipopeptide–NBD resided similarly in the glycerol
region in PS liposomes, with the tetralysine moiety
interacting with negative charges. However, NBD
was displaced towards the water phase in the absence
of a net negative charge in PC liposomes, due to a
tetralysine moiety dipping into water.
The three palmitoyl chains can insert within the
phospholipid acyl chains, and comparison of the data
 .obtained from compression isotherms Fig. 3 and
from lipopeptide insertion in preformed monolayers
  ..Fig. 2 B strongly suggests that up to 20 mNrm,
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palmitoyl residues were inserted within the hy-
drophobic part of monolayers. Above 20 mNrm, the
surface pressure at the plateau is lower than the value
expected from the compression isotherm correspond-
ing to the lipopeptiderPS 1r3 ratio, and above
29 mNrm, the interaction is not detected. One could
conclude that between 20 and 29 mNrm the two
interacting molecules were present in a ratio below
1r3. However, the surface potential DV of a mono-
layer reaching a surface pressure of 27 mNrm upon
interaction with the lipopeptide, showed the same
 .value 350 mV than a neutral preformed 1.lipo-
peptider3.PS monolayer. This suggests that even at
27 mNrm, the lipopeptide interaction is able to neu-
tralize the phospholipid layer. In this case, it must be
assumed that not all lipopeptide molecules interacted
in the same way with phospholipids, since the final
surface pressure was lower than that expected
 .32 mNrm from compression isotherms. It was not
possible to analyse further the interaction with the
methods used in the present work. Surface charge
neutralization was also detected in the interaction of
 .the lipopeptide with liposomes LUV by using the
 .fluorescence of TNS Fig. 7 .
Four important consequences resulted from
lipopeptide insertion in anionic phospholipid layers:
 .  .i liposome aggregation; ii exchange of phospho-
 .  .lipids between aggregated liposomes Fig. 6 ; iii
efficient displacement of calcium ions adsorbed on
  ..  .the phospholipid layer Fig. 9 B ; iv inhibition of
 .calcium-induced fusion of liposomes Fig. 8 , likely
due to calcium displacement from liposome surface.
In addition, the lipopeptide could induce some segre-
gation of anionic phospholipids.
Some of the above effects have been reported in
literature for polylysine, e.g. liposome aggregation
w xand phospholipid exchange 36,38 , but not with pep-
tides shorter than pentalysine. An important differ-
ence between polylysine and lipopeptide effects is
that this cationic lipopeptide inhibited the calcium-in-
w xduced fusion, while polylysine facilitated it 36 . This
underlines the importance of the three acyl chains in
the interaction: they help to bind the lipopeptide in
the membrane, anchoring the positive charges at the
interface, rendering them efficient competitors to cal-
cium ions.
It can be argueded that such an effect can take
place in leucocytes, on the inner as well on the outer
surface of the cell plasma membrane, since
macrophages rapidly internalize this type of molecule
w x42 . It has already been shown that the lipopeptide
induces calcium release within some blood cells
w x43,44 . Such an effect could disturb calcium-depen-
dent events, and it could be at the origin of some of
the observed pleiotropic activity of this lipopeptide.
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